Ibuprofen (1.5 M) or 3-PLG-ibu and 3-PLG-ibu-A-GSH nanocarriers (100 g/ml) were added as co-treatments
Oncogene 35 , 57955806 (2016)
At LumaLex Law, we help wellness centers, medical spas, supplement brands, and health businesses understand these rules so they can make safe decisions
It is not medical advice and should not be used as a substitute for professional evaluation, diagnosis, or treatment from a qualified healthcare provider
Ethical approval and consent to participate All methods were performed in accordance with the relevant guidelines and regulations
Included participants were aged between 30 and 65 years with Fitzpatrick IV and V Skin Types and were working a maximum of eight hours per day in an office environment